Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.665
AS - Asia 4.097
EU - Europa 2.853
SA - Sud America 672
AF - Africa 118
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.408
SG - Singapore 1.546
CN - Cina 800
HK - Hong Kong 600
RU - Federazione Russa 566
DE - Germania 560
VN - Vietnam 546
BR - Brasile 483
IT - Italia 391
IE - Irlanda 325
SE - Svezia 300
CA - Canada 202
GB - Regno Unito 160
FR - Francia 150
IN - India 128
AT - Austria 105
UA - Ucraina 85
AR - Argentina 72
ID - Indonesia 66
KR - Corea 63
BD - Bangladesh 62
FI - Finlandia 49
IQ - Iraq 43
ZA - Sudafrica 41
PK - Pakistan 40
TR - Turchia 39
MX - Messico 35
JP - Giappone 33
EC - Ecuador 32
DK - Danimarca 29
CO - Colombia 26
PL - Polonia 25
SA - Arabia Saudita 24
ES - Italia 21
UZ - Uzbekistan 20
NL - Olanda 19
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 14
EG - Egitto 13
PY - Paraguay 12
TN - Tunisia 12
CL - Cile 11
MY - Malesia 10
PE - Perù 10
AU - Australia 9
ET - Etiopia 8
TH - Thailandia 8
JO - Giordania 7
KE - Kenya 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
KG - Kirghizistan 6
SN - Senegal 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
LT - Lituania 5
MK - Macedonia 5
NG - Nigeria 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
IR - Iran 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BH - Bahrain 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
MU - Mauritius 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
GR - Grecia 1
Totale 14.407
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 854
Hong Kong 585
Ashburn 520
Fairfield 495
San Jose 450
Frankfurt am Main 414
Chandler 316
Dublin 313
Wilmington 257
Woodbridge 221
Houston 215
New York 208
Seattle 208
Dallas 182
Ho Chi Minh City 163
Toronto 152
Dearborn 139
Milan 139
Beijing 136
Princeton 130
Cambridge 124
Hanoi 118
Chicago 117
Santa Clara 110
Los Angeles 109
The Dalles 108
Vienna 96
Hefei 81
Moscow 76
Jacksonville 73
Lauterbourg 69
Altamura 58
Lawrence 56
Seoul 56
Nanjing 50
Shanghai 46
Buffalo 45
São Paulo 44
Jakarta 41
Council Bluffs 37
San Diego 34
Dong Ket 33
Munich 30
Haiphong 28
Atlanta 27
London 27
Helsinki 25
Da Nang 24
Guangzhou 23
Lissone 23
Orem 23
Tokyo 23
Baghdad 22
Boardman 21
Montreal 20
Andover 19
Salt Lake City 19
Nanchang 17
Tashkent 17
Warsaw 17
Brooklyn 15
Kunming 15
Jiaxing 14
San Francisco 14
Shenyang 14
Belo Horizonte 13
Mumbai 13
Rio de Janeiro 13
Brussels 12
Changsha 12
Chennai 12
Columbus 12
Nuremberg 12
Poplar 12
Tianjin 12
Denver 11
Johannesburg 11
Lahore 11
Phoenix 11
Jeddah 10
Jinan 10
Quito 10
Brasília 9
Cairo 9
Hebei 9
Manchester 9
Pune 9
Falls Church 8
Hangzhou 8
Lappeenranta 8
Mexico City 8
Turku 8
Addis Ababa 7
Bexley 7
Biên Hòa 7
Dhaka 7
Düsseldorf 7
Edmonton 7
Lachine 7
Totale 9.363
Salva come PNG Salva come JPEG
Nome #
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 339
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 325
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 316
Heart rate as cardiovascular risk factor 302
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 275
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 274
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 270
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 270
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 268
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 265
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 259
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 254
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 251
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 249
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 239
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 231
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 229
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 229
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 226
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 222
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 218
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 217
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 204
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 201
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 199
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 191
The role of carotid baroreceptor stimulation 191
Effects of Renal Denervation on Sympathetic Nervous System Activity 190
Baroreflex activation therapy systems: current status and future prospects 189
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 189
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 185
Obesity and Hypertension 179
Sympathetic Nervous System, Sleep, and Hypertension 179
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 176
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 176
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 174
The role of brain in neurogenic prehypertension 171
Blood pressure measurement, white-coat and masked hypertension 171
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 168
Elevated heart rate as sympathetic biomarker in human obesity 166
Sympatho-Vagal Imbalance in Hypertension 163
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 162
New-onset aortic dilatation in the population: a quarter-century follow-up 162
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 160
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 159
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 158
Heart rate as a predictor of cardiovascular risk 158
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 155
Obesity and hypertension 153
Lercanidipine in the management of hypertension: An update 152
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 151
Sleep Apnea and Hypertension 151
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 148
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 147
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 145
Cigarette smoking and the adrenergic nervous system 141
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 140
Device-Based Treatment in Hypertension and Heart Failure 139
Clinical relevance of the sympathetic–vascular interactions in health and disease 139
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 138
Treatment of resistant hypertension 137
Cardiovascular physiology: regulation of blood pressure 136
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 136
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 135
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 135
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 134
Neural Mechanisms 133
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 130
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 128
Baroreceptor Stimulation 126
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 125
Neurohormonal interactions 122
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 121
Sympathetic Activity in Hypertension and Heart Failure 116
Arterial alterations in hypertension 115
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 110
Microvascular Alterations in Obesity 107
Sympathomodulation in congestive heart failure: From drugs to devices 106
Trained Athletes 105
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 103
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 98
The sympathetic nervous system in hypertension 97
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 91
Totale 14.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 0 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20265.391 519 310 489 665 653 319 950 299 455 496 236 0
Totale 14.794